Hepatic Imaging in the 21st Century

 

 Buy Article Permissions and Reprints

ABSTRACT

Imaging of the liver has progressed rapidly during the past decade with continued advancement of current ultrasound, computed tomography, and magnetic resonance imaging (MRI). Each modality not only has seen refinement enabling better anatomic characterization of disease but also has received strength from the addition of new techniques to its resources. New contrast agents have become available for all modalities and some agents, particularly for MRI, have opened the way for better functional assessment. MRI continues to see an elaboration of sequences (including spectroscopy and diffusion) that also open imaging to the microscopic structure of disease and normal function. The further development of workstations have improved both analysis and depiction of disease. In the 21st century imaging will continue to shift from a simple source of anatomic information to a more functional problem-solving tool.

REFERENCES

• 1 Gambarin-Gelwan M, Wolf D C, Shapiro R, Schwartz M E, Min A D. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation.  Am J Gastroenterol. 2000;  95 1535-1538
  CrossrefPubMedGoogle Scholar
• 2 Chalasani N, Horlander Sr J C, Said A et al.. Screening for hepatocellular carcinoma in patients with advanced cirrhosis.  Am J Gastroenterol. 1999;  94 2988-2993
  CrossrefPubMedGoogle Scholar
• 3 Federle M P. Use of radiologic techniques to screen for hepatocellular carcinoma.  J Clin Gastroenterol. 2002;  35 S92-S100
  CrossrefPubMedGoogle Scholar
• 4 Colli A, Fraquelli M, Casazza G et al.. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review.  Am J Gastroenterol. 2006;  101 513-523
  CrossrefPubMedGoogle Scholar
• 5 Dodd III G D, Zajko A B, Orons P D, Martin M S, Eichner L S, Santaguida L A. Detection of transjugular intrahepatic portosystemic shunt dysfunction: value of duplex Doppler sonography.  AJR Am J Roentgenol. 1995;  164 1119-1124
  PubMedGoogle Scholar
• 6 Haskal Z J, Carroll J W, Jacobs J E et al.. Sonography of transjugular intrahepatic portosystemic shunts: detection of elevated portosystemic gradients and loss of shunt function.  J Vasc Interv Radiol. 1997;  8 549-556
  PubMedGoogle Scholar
• 7 Zizka J, Elias P, Krajina A et al.. Value of Doppler sonography in revealing transjugular intrahepatic portosystemic shunt malfunction: a 5-year experience in 216 patients.  AJR Am J Roentgenol. 2000;  175 141-148
  PubMedGoogle Scholar
• 8 Kok T, Slooff M J, Thijn C J et al.. Routine Doppler ultrasound for the detection of clinically unsuspected vascular complications in the early postoperative phase after orthotopic liver transplantation.  Transpl Int. 1998;  11 272-276
  CrossrefPubMedGoogle Scholar
• 9 Uzochukwu L N, Bluth E I, Smetherman D H et al.. Early postoperative hepatic sonography as a predictor of vascular and biliary complications in adult orthotopic liver transplant patients.  AJR Am J Roentgenol. 2005;  185 1558-1570
  CrossrefPubMedGoogle Scholar
• 10 Fuss M, Salter B J, Cavanaugh S X et al.. Daily ultrasound-based image-guided targeting for radiotherapy of upper abdominal malignancies.  Int J Radiat Oncol Biol Phys. 2004;  59 1245-1256
  CrossrefPubMedGoogle Scholar
• 11 Milsom J W, Jerby B L, Kessler H, Hale J C, Herts B R, O'Malley C M. Prospective, blinded comparison of laparoscopic ultrasonography vs. contrast-enhanced computerized tomography for liver assessment in patients undergoing colorectal carcinoma surgery.  Dis Colon Rectum. 2000;  43 44-49
  PubMedGoogle Scholar
• 12 Foroutani A, Garland A M, Berber E et al.. Laparoscopic ultrasound vs triphasic computed tomography for detecting liver tumors.  Arch Surg. 2000;  135 933-938
  CrossrefPubMedGoogle Scholar
• 13 Cervone A, Sardi A, Conaway G L. Intraoperative ultrasound (IOUS) is essential in the management of metastatic colorectal liver lesions.  Am Surg. 2000;  66 611-615
  PubMedGoogle Scholar
• 14 Leen E, Angerson W J, Yarmenitis S et al.. Multi-centre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions.  Eur J Radiol. 2002;  41 200-206
  CrossrefPubMedGoogle Scholar
• 15 Beissert M, Delorme S, Mutze S et al.. Comparison of B-mode and conventional colour/power Doppler ultrasound, contrast-enhanced Doppler ultrasound and spiral CT in the diagnosis of focal lesions of the liver: results of a multicentre study.  Ultraschall Med. 2002;  23 245-250
  PubMedGoogle Scholar
• 16 von Herbay A, Vogt C, Willers R, Haussinger D. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions.  J Ultrasound Med. 2004;  23 1557-1568
  PubMedGoogle Scholar
• 17 Quaia E, D'Onofrio M, Palumbo A, Rossi S, Bruni S, Cova M. Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence.  Eur Radiol. 2006;  16 1599-1609
  CrossrefPubMedGoogle Scholar
• 18 Leen E, Ceccotti P, Kalogeropoulou C, Angerson W J, Moug S J, Horgan P G. Prospective multicenter trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography.  AJR Am J Roentgenol. 2006;  186 1551-1559
  CrossrefPubMedGoogle Scholar
• 19 Hollett M D, Jeffrey Jr R B, Nino-Murcia M, Jorgensen M J, Harris D P. Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms.  AJR Am J Roentgenol. 1995;  164 879-884
  PubMedGoogle Scholar
• 20 Oliver III J H, Baron R L, Federle M P, Rockette Jr H E. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging.  AJR Am J Roentgenol. 1996;  167 71-77
  PubMedGoogle Scholar
• 21 Yeh B M, Breiman R S, Taouli B, Qayyum A, Roberts J P, Coakley F V. Biliary tract depiction in living potential liver donors: comparison of conventional MR, mangafodipir trisodium-enhanced excretory MR, and multi-detector row CT cholangiography-initial experience.  Radiology. 2004;  230 645-651
  CrossrefPubMedGoogle Scholar
• 22 Wang Z J, Yeh B M, Roberts J P, Breiman R S, Qayyum A, Coakley F V. Living donor candidates for right hepatic lobe transplantation: evaluation at CT cholangiography-initial experience.  Radiology. 2005;  235 899-904
  PubMedGoogle Scholar
• 23 Matsui O, Takashima T, Kadoya M et al.. Liver metastases from colorectal cancers: detection with CT during arterial portography.  Radiology. 1987;  165 65-69
  PubMedGoogle Scholar
• 24 Heiken J P, Weyman P J, Lee J K et al.. Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging.  Radiology. 1989;  171 47-51
  PubMedGoogle Scholar
• 25 Kondo H, Kanematsu M, Hoshi H et al.. Preoperative detection of malignant hepatic tumors: comparison of combined methods of MR imaging with combined methods of CT.  AJR Am J Roentgenol. 2000;  174 947-954
  PubMedGoogle Scholar
• 26 Semelka R C, Martin D R, Balci C, Lance T. Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement.  J Magn Reson Imaging. 2001;  13 397-401
  CrossrefPubMedGoogle Scholar
• 27 Rode A, Bancel B, Douek P et al.. Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver.  J Comput Assist Tomogr. 2001;  25 327-336
  CrossrefPubMedGoogle Scholar
• 28 Libbrecht L, Bielen D, Verslype C et al.. Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations.  Liver Transpl. 2002;  8 749-761
  CrossrefPubMedGoogle Scholar
• 29 Burrel M, Llovet J M, Ayuso C et al.. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation.  Hepatology. 2003;  38 1034-1042
  CrossrefPubMedGoogle Scholar
• 30 Soyer P, de Givry S C, Gueye C, Lenormand S, Somveille E, Scherrer A. Detection of focal hepatic lesions with MR imaging: prospective comparison of T2-weighted fast spin-echo with and without fat suppression, T2-weighted breath-hold fast spin-echo, and gadolinium chelate-enhanced 3D gradient-recalled imaging.  AJR Am J Roentgenol. 1996;  166 1115-1121
  PubMedGoogle Scholar
• 31 Fujita T, Ito K, Honjo K, Okazaki H, Matsumoto T, Matsunaga N. Detection of hepatocellular carcinoma: comparison of T2-weighted breath-hold fast spin-echo sequences and high-resolution dynamic MR imaging with a phased-array body coil.  J Magn Reson Imaging. 1999;  9 274-279
  CrossrefPubMedGoogle Scholar
• 32 Coulam C H, Chan F P, Li K C. Can a multiphasic contrast-enhanced three-dimensional fast spoiled gradient-recalled echo sequence be sufficient for liver MR imaging?.  AJR Am J Roentgenol. 2002;  178 335-341
  PubMedGoogle Scholar
• 33 Hecht E M, Holland A E, Israel G M et al.. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis.  Radiology. 2006;  239 438-447
  CrossrefPubMedGoogle Scholar
• 34 Sodickson A, Mortele K J, Barish M A, Zou K H, Thibodeau S, Tempany C M. Three-dimensional fast-recovery fast spin-echo MRCP: comparison with two-dimensional single-shot fast spin-echo techniques.  Radiology. 2006;  238 549-559
  CrossrefPubMedGoogle Scholar
• 35 Kapoor V, Peterson M S, Baron R L, Patel S, Eghtesad B, Fung J J. Intrahepatic biliary anatomy of living adult liver donors: correlation of mangafodipir trisodium-enhanced MR cholangiography and intraoperative cholangiography.  AJR Am J Roentgenol. 2002;  179 1281-1286
  PubMedGoogle Scholar
• 36 Bridges M D, May G R, Harnois D M. Diagnosing biliary complications of orthotopic liver transplantation with mangafodipir trisodium-enhanced MR cholangiography: comparison with conventional MR cholangiography.  AJR Am J Roentgenol. 2004;  182 1497-1504
  PubMedGoogle Scholar
• 37 Goyen M, Schroeder T, Ruehm S G, Debatin J F. MR-based assessment of potential living related liver donors.  Eur Radiol. 2004;  14(suppl 7) O36-O40
  PubMedGoogle Scholar
• 38 Akin E B, Vitellas K M, Rajab A et al.. Magnetic resonance cholangiography with mangafodipir trisodium (Teslascan) to evaluate bile duct leaks after T-tube removal in liver transplantation.  J Comput Assist Tomogr. 2004;  28 613-616
  PubMedGoogle Scholar
• 39 Ayuso J R, Ayuso C, Bombuy E et al.. Preoperative evaluation of biliary anatomy in adult live liver donors with volumetric mangafodipir trisodium enhanced magnetic resonance cholangiography.  Liver Transpl. 2004;  10 1391-1397
  CrossrefPubMedGoogle Scholar
• 40 Lee V S, Krinsky G A, Nazzaro C A et al.. Defining intrahepatic biliary anatomy in living liver transplant donor candidates at mangafodipir trisodium-enhanced MR cholangiography versus conventional T2-weighted MR cholangiography.  Radiology. 2004;  233 659-666
  CrossrefPubMedGoogle Scholar
• 41 Lim J S, Kim M J, Kim J H et al.. Preoperative MRI of potential living-donor-related liver transplantation using a single dose of gadobenate dimeglumine.  AJR Am J Roentgenol. 2005;  185 424-431
  PubMedGoogle Scholar
• 42 Moseley M E, Cohen Y, Mintorovitch J et al.. Early detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy.  Magn Reson Med. 1990;  14 330-346
  PubMedGoogle Scholar
• 43 Taouli B, Vilgrain V, Dumont E, Daire J L, Fan B, Menu Y. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients.  Radiology. 2003;  226 71-78
  PubMedGoogle Scholar
• 44 Quan X Y, Sun X J, Yu Z J, Tang M. Evaluation of diffusion weighted imaging of magnetic resonance imaging in small focal hepatic lesions: a quantitative study in 56 cases.  Hepatobiliary Pancreat Dis Int. 2005;  4 406-409
  PubMedGoogle Scholar
• 45 Sun X J, Quan X Y, Huang F H, Xu Y K. Quantitative evaluation of diffusion-weighted magnetic resonance imaging of focal hepatic lesions.  World J Gastroenterol. 2005;  11 6535-6537
  PubMedGoogle Scholar
• 46 Nasu K, Kuroki Y, Nawano S et al.. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging.  Radiology. 2006;  239 122-130
  PubMedGoogle Scholar
• 47 Boulanger Y, Amara M, Lepanto L et al.. Diffusion-weighted MR imaging of the liver of hepatitis C patients.  NMR Biomed. 2003;  16 132-136
  CrossrefPubMedGoogle Scholar
• 48 Koinuma M, Ohashi I, Hanafusa K, Shibuya H. Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis.  J Magn Reson Imaging. 2005;  22 80-85
  CrossrefPubMedGoogle Scholar
• 49 Ross B D, Moffat B A, Lawrence T S et al.. Evaluation of cancer therapy using diffusion magnetic resonance imaging.  Mol Cancer Ther. 2003;  2 581-587
  PubMedGoogle Scholar
• 50 Chen C Y, Li C W, Kuo Y T et al.. Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants-initial experience.  Radiology. 2006;  239 448-456
  CrossrefPubMedGoogle Scholar
• 51 Jackson A, Haroon H, Zhu X P, Li K L, Thacker N A, Jayson G. Breath-hold perfusion and permeability mapping of hepatic malignancies using magnetic resonance imaging and a first-pass leakage profile model.  NMR Biomed. 2002;  15 164-173
  CrossrefPubMedGoogle Scholar
• 52 Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers B E. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension.  Radiology. 2003;  229 409-414
  CrossrefPubMedGoogle Scholar
• 53 Yoshioka H, Takahashi N, Yamaguchi M, Lou D, Saida Y, Itai Y. Double arterial phase dynamic MRI with sensitivity encoding (SENSE) for hypervascular hepatocellular carcinomas.  J Magn Reson Imaging. 2002;  16 259-266
  CrossrefPubMedGoogle Scholar
• 54 Tanoli T, Yue P, Yablonskiy D, Schonfeld G. Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity.  J Lipid Res. 2004;  45 941-947
  CrossrefPubMedGoogle Scholar
• 55 Machann J, Thamer C, Schnoedt B et al.. Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy.  Magn Reson Med. 2006;  55 913-917
  CrossrefPubMedGoogle Scholar
• 56 Cho S G, Kim M Y, Kim H J et al.. Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings.  Radiology. 2001;  221 740-746
  PubMedGoogle Scholar
• 57 Lim A K, Patel N, Hamilton G, Hajnal J V, Goldin R D, Taylor-Robinson S D. The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C.  Hepatology. 2003;  37 788-794
  CrossrefPubMedGoogle Scholar
• 58 Dezortova M, Taimr P, Skoch A, Spicak J, Hajek M. Etiology and functional status of liver cirrhosis by 31P MR spectroscopy.  World J Gastroenterol. 2005;  11 6926-6931
  PubMedGoogle Scholar
• 59 Zakian K L, Koutcher J A, Malhotra S et al.. Liver regeneration in humans is characterized by significant changes in cellular phosphorus metabolism: assessment using proton-decoupled 31P-magnetic resonance spectroscopic imaging.  Magn Reson Med. 2005;  54 264-271
  CrossrefPubMedGoogle Scholar
• 60 Chu W C, Lam W W, Lee K H, Yeung D K, Sihoe J, Yeung C K. Phosphorus-31 MR spectroscopy in pediatric liver transplant recipients: a noninvasive assessment of graft status with correlation with liver function tests and liver biopsy.  AJR Am J Roentgenol. 2005;  184 1624-1629
  PubMedGoogle Scholar
• 61 Planchamp C, Montet X, Frossard J L et al.. Magnetic resonance imaging with hepatospecific contrast agents in cirrhotic rat livers.  Invest Radiol. 2005;  40 187-194
  CrossrefPubMedGoogle Scholar
• 62 Matsuo M, Kanematsu M, Itoh K et al.. Detection of malignant hepatic tumors: comparison of gadolinium- and ferumoxide-enhanced MR imaging.  AJR Am J Roentgenol. 2001;  177 637-643
  PubMedGoogle Scholar
• 63 Kwak H S, Lee J M, Kim Y K, Lee Y H, Kim C S. Detection of hepatocellular carcinoma: comparison of ferumoxides-enhanced and gadolinium-enhanced dynamic three-dimensional volume interpolated breath-hold MR imaging.  Eur Radiol. 2005;  15 140-147
  CrossrefPubMedGoogle Scholar
• 64 Simon G, Link T M, Wortler K et al.. Detection of hepatocellular carcinoma: comparison of Gd-DTPA- and ferumoxides-enhanced MR imaging.  Eur Radiol. 2005;  15 895-903
  CrossrefPubMedGoogle Scholar
• 65 Kato H, Kanematsu M, Kondo H et al.. Ferumoxide-enhanced MR imaging of hepatocellular carcinoma: correlation with histologic tumor grade and tumor vascularity.  J Magn Reson Imaging. 2004;  19 76-81
  CrossrefPubMedGoogle Scholar
• 66 Kim Y K, Lee J M, Kim C S, Chung G H, Kim C Y, Kim I H. Detection of liver metastases: gadobenate dimeglumine-enhanced three-dimensional dynamic phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced MR imaging.  Eur Radiol. 2005;  15 220-228
  CrossrefPubMedGoogle Scholar
• 67 Bartolozzi C, Donati F, Cioni D et al.. Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT.  Eur Radiol. 2004;  14 14-20
  CrossrefPubMedGoogle Scholar
• 68 Youk J H, Lee J M, Kim C S. MRI for detection of hepatocellular carcinoma: comparison of mangafodipir trisodium and gadopentetate dimeglumine contrast agents.  AJR Am J Roentgenol. 2004;  183 1049-1054
  PubMedGoogle Scholar
• 69 Scharitzer M, Schima W, Schober E et al.. Characterization of hepatocellular tumors: value of mangafodipir-enhanced magnetic resonance imaging.  J Comput Assist Tomogr. 2005;  29 181-190
  CrossrefPubMedGoogle Scholar
• 70 Sahani D V, Kalva S P, Fischman A J et al.. Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.  AJR Am J Roentgenol. 2005;  185 239-246
  CrossrefPubMedGoogle Scholar
• 71 Regge D, Campanella D, Anselmetti G C et al.. Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma.  Clin Radiol. 2006;  61 338-347
  CrossrefPubMedGoogle Scholar
• 72 Gondolesi G E, Yoshizumi T, Bodian C et al.. Accurate method for clinical assessment of right lobe liver weight in adult living-related liver transplant.  Transplant Proc. 2004;  36 1429-1433
  CrossrefPubMedGoogle Scholar
• 73 Harada N, Shimada M, Yoshizumi T, Suehiro T, Soejima Y, Maehara Y. A simple and accurate formula to estimate left hepatic graft volume in living-donor adult liver transplantation.  Transplantation. 2004;  77 1571-1575
  PubMedGoogle Scholar
• 74 Salvalaggio P R, Baker T B, Koffron A J et al.. Liver graft volume estimation in 100 living donors: measure twice, cut once.  Transplantation. 2005;  80 1181-1185
  CrossrefPubMedGoogle Scholar
• 75 Dodd III G D, Baron R L, Oliver III J H, Federle M P. Spectrum of imaging findings of the liver in end-stage cirrhosis: part II, focal abnormalities.  AJR Am J Roentgenol. 1999;  173 1185-1192
  PubMedGoogle Scholar
• 76 Krinsky G A, Israel G. Nondysplastic nodules that are hyperintense on T1-weighted gradient-echo MR imaging: frequency in cirrhotic patients undergoing transplantation.  AJR Am J Roentgenol. 2003;  180 1023-1027
  PubMedGoogle Scholar
• 77 Yu J S, Kim Y H, Rofsky N M. Dynamic subtraction magnetic resonance imaging of cirrhotic liver: assessment of high signal intensity lesions on nonenhanced T1-weighted images.  J Comput Assist Tomogr. 2005;  29 51-58
  CrossrefPubMedGoogle Scholar
• 78 Sugiyama M, Sakahara H, Torizuka T et al.. 18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma.  J Gastroenterol. 2004;  39 961-968
  CrossrefPubMedGoogle Scholar

Emil CohenM.D. 

Department of Radiology, Box 1234, Mount Sinai Medical Center, One Gustave L. Levy Place

New York, NY 10029-6574

Email: emil.cohen@mountsinai.org